The departments proposal would only affect prescriptions for weight loss, and it would still cover prescriptions for diabetes, which the GLP-1 drugs were first used to treat
Both medications are approved for weight loss if an individuals BMI is 30 or higher, or 27 if there are risk factors
Tirzepatide patients lost an average of 20.2% of their body weight, while semaglutide patients lost 13.7%, a difference of 6.5 percentage points.[1] In practical terms, for someone starting at 250 pounds, that means losing roughly 50 pounds (22.8 kg) on tirzepatide versus 33 pounds (15.0 kg) on semaglutide.[1] Waist circumference shrank by an average of 7.2 inches (18.4 cm) with tirzepatide versus 5.1 inches (13.0 cm) with semaglutide, a difference with real implications for heart disease risk.[1] When researchers looked at more dramatic weight loss thresholds, tirzepatide pulled further ahead
For lipedema patients, GLP-1s present a spectrum of potential benefits
Constipation on Tirzepatide or Semaglutide (GLP-1): A Step-by-Step MD Fix Joshua Silva, MD Jan 31 5 min read Updated: Feb 2 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Definition Constipation on GLP-1 medications refers to infrequent, hard, or difficult-to-pass stools caused by medication-related slowing of gastrointestinal motility . The Quick Fix: How do I relieve constipation on GLP-1 medications
